Gabapentin Capsule
Product Images NDC 55154-7993

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 55154-7993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D5ccd1ed 17ec 4f79 B838 8a10dab4179a 00

Gabapentin Capsules, USP 100 mg package label showing a 10-capsule count. The label includes dosing information, storage instructions, and warnings. Manufactured by Alkerm Laboratories Ltd, India, and distributed by Ascend Laboratories LLC, Major® Pharmaceuticals, and Cardinal Health. NDC 55154-3363-0 is visible.*

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

A formula describing creatinine clearance (CLCr) calculation, incorporating age in years, weight in kg, serum creatinine in mg/dL, and a factor of 0.85 for female patients. The formula relates to pharmacokinetic or dosing considerations.*

FDA Label Image

Gabapentin Fig1

A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. Gabapentin is indicated by a line with triangles and placebo by a line with circles, with Gabapentin consistently showing lower mean pain scores throughout the study period.*

FDA Label Image

Gabapentin Fig2

A line graph showing mean pain scores over 7 weeks for placebo and two dosages of Gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks, divided into a 3-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain scores from 0 to 10. Gabapentin groups show a decrease in mean pain scores over time compared to placebo.*

FDA Label Image

Gabapentin Fig3

Bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) treatments across two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% responders for PBO, 32% for GBP 1800 mg, and 34% for GBP 2400 mg.*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

A scatter plot showing percentage difference versus daily dose in mg for Gabapentin from three studies labeled a, b, and c. The x-axis indicates daily doses of approximately 600, 900, 1200, and 1800 mg, while the y-axis displays difference percentages from 2% to 22%. Data points are marked with distinct symbols and letters for each study.*

FDA Label Image

Gabapentin-struc (Gabapentin Struc)

Chemical structure of Gabapentin, showing a cyclohexane ring with an amino group (CH2NH2) and a carboxymethyl group (CH2CO2H) attached to the ring.*

FDA Label Image

Image 01

Gabapentin Capsules, USP 300 mg oral dosage form shown on a label for a package of 10 capsules. The label includes storage instructions, warning for institutional use only, and pharmacist dispensing guidance. Manufactured by Alkem Laboratories Ltd., distributed by Ascend Laboratories, Major Pharmaceuticals, and Cardinal Health.*

FDA Label Image

Image 02

Label for Gabapentin Capsules, USP 400 mg, with a count of 10 capsules. The label includes storage instructions, a pharmacist dispensing note, and manufacturing and distribution details for Alkem Laboratories Ltd, Ascend Laboratories LLC, Major Pharmaceuticals, and Cardinal Health. The label is for oral capsules and marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.